Drug Search Results
More Filters [+]

Mangafodipir

Alternative Names: mangafodipir, teslascan
Latest Update: 2024-12-12
Latest Update Note: Clinical Trial Update

Product Description

Mangafodipir is an MRI (magnetic resonance imaging) contrast agent (also known as paramagnetic agents). MRI agents are used to help provide a clear picture during MRI. MRI is a special kind of diagnostic procedure. It uses magnets and computers to create images or “pictures” of certain areas inside the body (Sourced from: https://www.mayoclinic.org/drugs-supplements/mangafodipir-intravenous-route/description/drg-20067273)

Mechanisms of Action: Contrast Agent

Novel Mechanism: No

Modality: Diagnostic Agent

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | European Medicines Agency | Germany | Greece | Hungary | Ireland | Italy | New Zealand | Portugal | Saudi Arabia | Slovenia | Sweden | Taiwan | Turkey | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mangafodipir

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title